The Edge of a New Frontier: Anti-TL1A Monoclonal Antibodies for Ulcerative Colitis

Evidence-Based GI: An ACG Publication and Podcast - A podcast by American College of Gastroenterology - Wednesdays

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Bharati Kochar, MD, MS discuss “Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis,” by Sands BE, Feagan BG, Biroulet LP, et al. N Engl J Med. 2024; 391: 1119-29.